Conference abstractPublished 8 Jun 2018
Antimicrobial activity of the uncombined and combined aqueous extract of Phyllanthus acidus, Sphagneticola trilobata leaves and Doliocarpus dentatus’s bark against human pathogenic microorganism in the absence and p
University of Guyana, Guyana
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The search for alternative complementary natural medicines to replace synthetic antibiotics is on the increase, considering the side effects produced by synthetic drugs, some of which are irreversible. The aqueous extract of leaves of Phyllanthus acidus, Sphagneticola trilobata and Doliocarpus dentatus’s bark, uncombined and combined in the absence and presence of Zn2+ were tested against selective pathogenic microorganism such as S. aureus, E.coli., K. pneumoniae, P. aeruginosa and C. albicans using the Disc Diffusion Assay. The area of zone of inhibition, Azoi was taken as an indicator of the plant extract’s antimicrobial potency. The highest Azoi of 165.05 mm2 was induced by P. acidus extract against E. coli. In the absence of Zn2+ , zero Azoi was observed for the combined extract of P. acidus + S. Trilobata, S. trilobata + D. dentatus and P. acidus + D. dentatus against S. aureus and K. pneumoniae. The combined plant extract, without Zn2+, seems to induce a higher Azoi against E. coli, K, pneumoniae, C. albicans and P. aeruginosa in comparison with the individual plant extract. As an example, the combined plant extract of S. trilobata and D. dentatus induces Azoi of 122.66 mm2, whereas S. trilobata induces AzoI of 117.79 mm2. For the combined plant extract with Zn2+, a lower Azoi was induced, compared with the individual plant extract. Selective antimicrobial activity was observed for the uncombined and combined extracts, with and without Zn2+ against some of the pathogens. For example, P. acidus aqueous extract showed Azoi of 165.1 mm2 against E. coli, whereas S. trilobata showed Azoi of 67.17 mm2 against E. coli i.e., a selectivity ratio of 2.5 vs. E.coli with respect to the above two extracts.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jagessar R C”
- BylineArticles whose byline prints “Hope S”
